首页> 外文OA文献 >Characteristics of Patients with Estrogen Receptor (ER)-Negative, Progesterone Receptor (PR)-Negative, and HER2-Negative Invasive Breast Cancer in Dr. Hasan Sadikin General Hospital, Bandung, Indonesia from 2010 to 2011

【2h】

Characteristics of Patients with Estrogen Receptor (ER)-Negative, Progesterone Receptor (PR)-Negative, and HER2-Negative Invasive Breast Cancer in Dr. Hasan Sadikin General Hospital, Bandung, Indonesia from 2010 to 2011

机译：雌激素受体（ER）患者的特征 - 中阴性，孕酮受体（PR） - 哈桑Sadikin综合医院博士，印度尼西亚博士博士博士博士的海参侵袭性乳腺癌

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Nadytia Kusumadjayanti; Dharmayanti Francisca Badudu; Bethy S. Hernowo;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Frequency of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from Trentino, North East Italy. [J] . GiulianiS., LeonardiE., AldoviniD., Pathologica . 2012,第3期

机译：雌激素受体（ER）阴性，孕激素受体（PR）阴性和HER2阴性浸润性乳腺癌的频率，即所谓的三阴性表型：来自意大利东北特伦蒂诺的一项基于人群的研究。
2. NOLUS: a predictive model to identify Basal-like and HER2-enriched intrinsic subtypes based on estrogen receptor (ER), progesterone receptor (PR) and Ki67 immunohistochemistry (IHC) in hormone receptor-positive/HER2-negative (HR+/HER2-) breast cancer (BC) [J] . Pascual T., Martin M., Pare L., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2018,第期

机译：nolus：一种基于雌激素受体（ER），孕酮受体（PR）和Ki67免疫组化（IHC）在激素受体阳性/ HER2阴性（HR + / HER2-）中的基于雌激素受体（ER），孕酮受体（PR）和KI67）的预测模型乳腺癌（BC）
3. Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer [J] . Chansub Park, Kyeongmee Park, Jiyoung Kim, World Journal of Surgical Oncology . 2016,第1期

机译：阴性B型HER2阴性乳腺癌患者雌激素或孕激素受体阴性的预后价值
4. Lipid profiles in breast cancer samples: Identification of glycosylated ceramides associated to estrogen and progesterone receptor negative tumors [C] . Heli Nygren, Mika Hilvo, Tuulia Hyotylainen, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2011

机译：乳腺癌样品中的脂质谱：鉴定与雌激素和孕酮受体阴性肿瘤相关的糖基化神经酰胺
5. Molecular aspects of targeting estrogen receptor (ER)-positive and ER-negative breast cancer cells. [D] . Venkiteswaran, Sripriya. 2006

机译：靶向雌激素受体（ER）阳性和ER阴性乳腺癌细胞的分子方面。
6. Ki-67 index value and progesterone receptor status can predict prognosis and suitable treatment in node-negative breast cancer patients with estrogen receptor-positive and HER2-negative tumors [O] . Nobuyuki Arima, Reiki Nishimura, Tomofumi Osako, -1

机译：Ki-67指数值和孕激素受体状态可预测具有雌激素受体阳性和HER2阴性肿瘤的淋巴结阴性乳腺癌患者的预后并进行适当治疗
7. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype [O] . Katrina R. Bauer, Monica Brown, Rosemary D. Cress, 2007

机译：对雌激素受体（ER）的描述性分析 - 阴茎，孕酮受体（PR） - 负和Her2阴性侵袭性乳腺癌，所谓的三重阴性表型
8. CSrc and Her2 Signaling Pathways Cooperate With Estrogen to Promote Estrogen Receptor Phosphorylation, Ubiquitination and Proteolysis in ER Negative Breast Cancers [R] . Chu, I. 2006

机译：Csrc和Her2信号通路与雌激素合作促进ER阴性乳腺癌中雌激素受体磷酸化，泛素化和蛋白水解

Characteristics of Patients with Estrogen Receptor (ER)-Negative, Progesterone Receptor (PR)-Negative, and HER2-Negative Invasive Breast Cancer in Dr. Hasan Sadikin General Hospital, Bandung, Indonesia from 2010 to 2011

著录项

引文网络

相似文献

相关主题

期刊订阅